2004
DOI: 10.1128/jcm.42.10.4918.2004
|View full text |Cite
|
Sign up to set email alerts
|

Use of DNA Microarrays for Rapid Genotyping of TEM Beta-Lactamases That Confer Resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
39
0

Year Published

2005
2005
2010
2010

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 30 publications
(39 citation statements)
references
References 0 publications
0
39
0
Order By: Relevance
“…One such application is the genotyping of SHV ␤-lactamases that confer resistance to extendedspectrum cephalosporins. Of the numerous post-PCR methods devised in the past, the most widely used are hybridizationbased assays including fluorescence-labeled oligonucleotide probes on a LightCycler instrument (25) or DNA microarrays (12), as well as PCR restriction analysis (2,18,23) and automated DNA sequencing (4). In this paper, we have introduced an improved method for comparative sequence analysis via base-specific cleavage of in vitro-transcribed RNA (29).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…One such application is the genotyping of SHV ␤-lactamases that confer resistance to extendedspectrum cephalosporins. Of the numerous post-PCR methods devised in the past, the most widely used are hybridizationbased assays including fluorescence-labeled oligonucleotide probes on a LightCycler instrument (25) or DNA microarrays (12), as well as PCR restriction analysis (2,18,23) and automated DNA sequencing (4). In this paper, we have introduced an improved method for comparative sequence analysis via base-specific cleavage of in vitro-transcribed RNA (29).…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, a number of competing post-PCR techniques for fast identification have been developed during the past few years. For example, PCR-restriction fragment length polymorphism analysis (2,18,23), fluorescence-labeled oligonucleotide probes used on a LightCycler instrument (25), and DNA microarrays (12) have been proposed to identify some of the relevant point mutations. However, the major drawback of all of the current assays is that they are not able to identify previously unknown sequence variations.…”
mentioning
confidence: 99%
“…In view of the increasing number of fungal species isolated from clinical samples as potential pathogens, a broad-spectrum detection system as it is represented by the microarray technology would be desirable. Until today, diagnostic DNA microarrays were applied for the identification of viruses (5,(27)(28)(29)56), bacteria (14,24,45,46,49), and mechanisms of resistance to certain antibiotics (15,18,55). To our knowledge, this study describes for the first time the application of the DNA microarray technology in combination with a quantification and data-processing method for the rapid and reliable detection of fungal pathogens.…”
Section: Discussionmentioning
confidence: 99%
“…DNA microarrays are used in three major clinical areas: (a) for gene expression profiling -measuring the expression level of thousands of genes in any tissue sample, (b) for genotyping -determination of diseaserelevant genes or agents causing diseases, and (c) DNA sequencing -screening thousands of DNA base pairs for mutations in specific genes whose normal sequence is already known (screening of single nucleotide polymorphisms, SNPs) 57 . Grimm et al 58 developed and validated oligonucleotide microarray for the rapid identification of ESBL in Gram-negative bacteria by simultaneously genotyping bla TEM , bla SHV and bla CTX-M . The array consisted of 168 probes which cover mutations responsible for 156 amino acid substitutions with the assay time of 5 hours.…”
Section: Real-time Pcrmentioning
confidence: 99%